Barcelona

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Alzheimer disease
• Mild cognitive impairment

Running trials

• Active, not recruiting

  Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study

  NCT04685590· Phase 2· Washington University School of Medicine· Source